Lonza human and animal hepatocytes for ADME-Tox testing

Friday, 17 March, 2017 | Supplied by: Capsugel Australia Pty Ltd

Lonza now offers a comprehensive portfolio of human and animal hepatocytes for ADME-Tox testing. The range includes both fresh and cryopreserved human and animal hepatocytes, supporting researchers with a variety of in vitro applications, including studies into drug metabolism and toxicity, drug-transporter activity and drug-drug interactions.

The hepatocyte portfolio also features hepatic non-parenchymal cells, such as stellate and Kupffer cells, which can improve the translatability of in vitro toxicity testing and pharmacokinetics research to clinical trials. The hepatocytes are prequalified for a variety of different applications, which helps to reduce time spent evaluating cells for specific experiments within the laboratory.

The range also includes supporting ADME-Tox products such as specialised hepatocyte media and cell culture systems, helping to optimise hepatocyte culture performance for in-vitro drug screening or for research into drug-induced liver injury and other important liver diseases.

Online: www.capsugel.com
Phone: 1300 657508
Related Products

Enzo Life Sciences SUPERKILLERTRAIL protein (soluble) (human), (recombinant)

Enzo Life Sciences' SUPERKILLERTRAIL (soluble) (human), (recombinant) is an enhanced ligand...

Diaclone ELISpot Kits

Diaclone's ELISpot Kits are highly specific immunoassays for the analysis of the production...

Bio-Rad Laboratories Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays

The assays allow scientists to measure neutralising antibodies quickly and efficiently against...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd